Pharmacy scope of practice and access to Opioid Agonist Therapies after COVID-19

Sarah Lussier-Hoskyn, MA Economics BPHA, affiliated researcher CHPI
Brett Skinner, PhD, CEO CHPI, Editor CHP Journal

Under the regulations contained in the federal Controlled Drugs and Substances Act (CDSA), prescribing, selling, distributing and other related activities involving drugs like opioids are only allowed for designated health professions. On March 19, 2020, Health Canada issued an exemption, temporarily expanding pharmacists’ scope of practice to include activities usually prohibited by the CDSA. The exemption was implemented partly to facilitate continuity of access to opioid agonist therapies (OAT) for people suffering from opioid use disorder (OUD) during the COVID-19 pandemic. This article discusses the implications of making the exemption permanent.

PREVIEW: January 27, 2022 | PUBLISHED: January 31, 2022

Comparing wait times for an Alzheimer’s treatment in Canada and other G7 countries

Soeren Mattke, MD DSc, University of Southern California, Los Angeles, USA
Mo Wang, MS, University of Southern California, Los Angeles, USA

The emerging disease-modifying Alzheimer’s treatments present a health system challenge because of the combination of a large prevalent patient pool and a complex diagnostic process. Analyses of system preparedness have projected Canada to have the longest and most protracted wait times for access among G7 countries. This policy analysis used comparative health system data and 17 semi-structured interviews with experts in Canada. The authors conclude that Canada faces a unique challenge to make a disease-modifying Alzheimer’s treatment accessible because of limited capacity for memory care.

PREVIEW: January 27, 2022 | PUBLISHED: January 31, 2022

Comparing COVID-19 Vaccine Procurement in Canada, the UK and Israel

Mayvis Rebeira, PhD, Affiliated Scholar, Canadian Health Policy Institute

This commentary article compares Canada’s vaccination procurement strategy with that of UK and Israel. Canada’s COVID-19 vaccine supply seemed unreliable in the early months of 2021 when both UK and Israel were able to procure a steady supply of vaccines for their population. As of the beginning of May 2021, Canada had only fully vaccinated (two doses administered) 3% of its population compared to Israel at 58% and UK at 23%. Canada eventually accelerated its vaccine distribution and by the end of August 2021, 66% of the population had been fully vaccinated.

PUBLISHED: September 23, 2021

CHPI celebrates 10 successful years and a new style for CHP Journal!


A note to CHPI Members and CHP Readers from Brett Skinner, Founder, CEO and Editor

CHPI Members and CHP Readers,

Did you know that the Canadian Health Policy Institute will celebrate its 10th anniversary in 2022? The Institute was established in 2012, as Canada’s first private-sector, non-governmental research organization specializing in health policy. CHPI is an entrepreneurial academic venture with a social purpose. It was founded in response to the observation that there are persistent problems in Canada’s healthcare system and established policies have not proved to be adequate to meet these challenges. The goal was to identify systemic problems and develop alternative policy options that would improve patients’ access to the most advanced medical care at a sustainable cost for taxpayers.

The venture has been successful. Over the last decade, CHPI has become an important voice in the health policy community, earning a reputation for evidence-based research and advocacy.

The Institute’s profile has grown since 2012. Almost 23,000 people now follow CHPI across various social media platforms generating nearly 4,000,000 unique post views. More than 70 original opinion editorials by CHPI researchers have been published in print and digital newspapers and magazines across the country. CHPI research is frequently cited in academic publications and major media.

Our digital online journal Canadian Health Policy, is an increasingly popular platform for independent researchers to publish evidence and ideas that shape health policy. Since 2012, CHP has recorded nearly 160,000 unique readers and is approaching 500,000 document views. The Journal now attracts approximately 30,000 active readers annually: an audience comprised almost entirely of people with a professional, occupational, or academic interest in knowing how government policies impact the health of Canadians and the performance of the healthcare system.

Nearly 150 studies and articles have been published in CHP, from 67 authors including 34 PhDs, 21 MDs, 2 PharmDs, 1 DDS, and other experts, economists and analysts. Author affiliations include research institutes, patient organizations, universities, hospitals, and government health agencies.

We are marking our 10th anniversary by relaunching the Journal with a new look and improved functionality. We have also adopted a new standardized style for our downloadable publications. I invite you to browse through the Journal. If you are not yet a subscriber, you can read some of our Open Access articles free of charge.

The credit for CHPI’s success ultimately belongs to our affiliated researchers, advisors, and administrators. Their intelligent work has made CHPI an important source of evidence and innovative policy thinking.

Finally, I want to thank you, our readers, for your interest in Canadian Health Policy over the last 10 years. Your support makes it possible for us to generate and publish information and ideas for a better health system.

Looking forward to the future!